🇺🇸 SRPT — Sarepta Therapeutics, Inc.

Salud Mantener
← Volver

Precio actual

17,57 USD

Máx. histórico

178,74

2144 días

Split 1:6 del 12/07/2012

Caída desde máximo

-90,17%

Rango 52 semanas

14,68 – 24,68

Variación hoy

-7,48%

Cierre anterior

18,99

Rango de hoy

17,44 – 18,92

Volumen hoy

1.859.162

Peor caída histórica

-98,17%

09/02/2000 → 18/12/2008

Recuperado en 3568 días

Volatilidad anualizada ⓘ

95,43%

Información
Nombre completo
Sarepta Therapeutics, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
835
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
21,64 USD (puede no estar actualizado)
Primera cotización
04/06/1997
Precio actualizado
hace 14 horas
Sobre la empresa

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, siRNA platform, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping; AMONDYS 45 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 45 skipping; and ELEVIDYS, an AAV-based gene therapy, which is contraindicated in patients with any deletion in exon 8 and/or exon 9 in the Duchenne gene. The company also develops SRP-9003, a gene therapy program for the treatment of LGMD2E; SRP-1001 to selectively target and knockdown DUX4 using RNAi in Phase 1/2a clinical trials; and SRP-1003 for reduction of expression of the DMPK gene in Phase 1/2a clinical trials. It has collaboration and license agreements with F. Hoffman-La Roche Ltd; Arrowhead Pharmaceuticals, Inc.; University of Western Australia; Nationwide Children's Hospital; Hansa Biopharma; and Duke University. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.

Splits Registrados en el histórico de precios
Fecha Ratio
12/07/2012 1:6
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
14/04/2020 111,73 114,95 111,42 113,05 +1,29% 3,16% 802.900
13/04/2020 109,00 111,97 107,10 111,61 +2,63% 4,47% 770.800
09/04/2020 104,50 109,15 103,94 108,75 +4,70% 4,99% 921.700
08/04/2020 100,65 105,19 100,18 103,87 +3,89% 4,98% 563.200
07/04/2020 104,37 106,39 99,33 99,98 -1,08% 6,76% 871.700
06/04/2020 98,28 101,31 96,20 101,07 +7,96% 5,20% 954.400
03/04/2020 94,69 97,48 92,00 93,62 -2,46% 5,79% 1.801.700
02/04/2020 92,15 98,29 91,53 95,98 +3,20% 7,34% 978.900
01/04/2020 95,69 99,88 92,36 93,00 -4,93% 7,86% 1.096.100
31/03/2020 98,84 102,61 95,46 97,82 -0,71% 7,23% 978.300
30/03/2020 94,78 98,68 93,01 98,52 +4,32% 5,98% 544.900
27/03/2020 96,83 98,99 94,00 94,44 -4,62% 5,15% 518.400
26/03/2020 95,40 103,09 95,40 99,01 +4,74% 8,06% 815.400
25/03/2020 91,82 99,44 91,82 94,53 +1,95% 8,30% 958.600
24/03/2020 92,79 97,90 91,28 92,72 +3,74% 7,13% 967.700
23/03/2020 87,60 93,58 85,38 89,38 +2,72% 9,36% 713.400
20/03/2020 88,48 94,84 85,62 87,01 -0,24% 10,42% 982.100
19/03/2020 81,09 90,81 78,39 87,22 +5,88% 15,32% 1.083.100
18/03/2020 83,00 91,97 78,06 82,38 -5,10% 16,76% 1.838.200
17/03/2020 86,87 94,74 81,71 86,81 +1,93% 15,00% 1.590.900
16/03/2020 88,95 96,27 83,02 85,17 -14,68% 14,90% 1.457.200
13/03/2020 97,95 100,00 89,09 99,83 +5,99% 11,14% 1.471.200
12/03/2020 95,00 97,94 90,01 94,19 -8,40% 8,35% 1.713.900
11/03/2020 107,95 109,62 99,94 102,83 -6,84% 8,97% 915.500
10/03/2020 109,58 111,85 102,69 110,38 +3,28% 8,36% 963.600
09/03/2020 108,37 115,51 105,89 106,87 -8,74% 8,88% 946.700
06/03/2020 117,67 122,44 115,11 117,10 -2,47% 6,23% 832.100
05/03/2020 117,36 123,96 116,23 120,06 +0,74% 6,59% 681.600
04/03/2020 119,16 119,67 115,59 119,18 +2,65% 3,42% 768.100
03/03/2020 119,94 120,82 112,95 116,10 -3,14% 6,56% 900.200